Escanilla, Pilar D.
HRN: 23-78-40 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2023
CEFUROXIME 1.5GM (VIAL)
11/11/2023
11/11/2023
IVT
1.5 Gms
On Call To OR
TAHBSO
Checking Final Appropriateness
11/11/2023
CEFUROXIME 1.5GM (VIAL)
11/11/2023
11/18/2023
IV
1.5g
Q8
S/ TAHBSO
Checking Final Appropriateness
11/12/2023
CEFUROXIME 500MG (TAB)
11/12/2023
11/18/2023
PO
500mg
BID
TAHBSO
Checking Final Appropriateness